CLINICAL_TRIALS
research
· 2007-04-27
Clinical Trial Update: Copaxone in Age Related Macular Degeneration [Phase 2, Phase 3]
Summary
Copaxone (glatiramer acetate) is being evaluated in phase 2/3 trials for age-related macular degeneration, and the study status is currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kaplan Medical Center | Conditions: Macular Degeneration | Phase 2, Phase 3 | Status: UNKNOWN